Search research articles
Contact Us
Filters
Showing results (141-150 of 184) with videos related to
Page
of 19
Sort By:
Thrombosis and Haemostasis
|
September 1, 1995
Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity
P Y Scarabin, G Plu-Bureau, D Zitoun, et al.
Thrombosis and Haemostasis
|
September 1, 1995
Human anti-streptokinase antibodies induce platelet aggregation in an Fc receptor (CD32) dependent manner
J Lebrazi, G Helft, M Abdelouahed, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
July 1, 1997
[Anti-streptokinase antibodies]
G Helft, T Lecompte, C Le Feuvre, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
September 24, 1999
Workshop I: The potential role of new therapies in deep vein thrombosis prophylaxis
A T Cohen, A S Gallus, S Haas, et al.
Journal of Clinical Pharmacology
|
July 1, 1988
The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg
A M Frydman, L Bara, Y Le Roux, et al.
Presse Medicale (Paris, France : 1983)
|
February 7, 1998
[Thrombogenicity of biomaterials in cardiovascular surgery. Methods for improving the thrombogenicity of cardiovascular prostheses]
G Babatasi, L Bara, M Massetti, et al.
Thrombosis and Haemostasis
|
May 1, 1997
Coronary stenting in a hemophilic patient
G Helft, J P Metzger, M M Samama, et al.
Seminars in Vascular Medicine
|
November 23, 2005
D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implications
M M Samama, M H Horellou, I Elalamy, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1995
Heparin- and streptokinase-dependent platelet-activating immunoglobulin G: mechanism and diagnosis
T Lecompte, N Stieltjes, L Shao-Kai, et al.
Presse Medicale (Paris, France : 1983)
|
February 7, 1998
[Thombogenicity of biomaterials in cardiovascular surgery. Thrombo-protection and different types of grafts]
G Babatasi, L Bara, M Massetti, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 184) with videos related to
Sort By:
Page
of 19
Thrombosis and Haemostasis
|
September 1, 1995
Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity
P Y Scarabin, G Plu-Bureau, D Zitoun, et al.
Thrombosis and Haemostasis
|
September 1, 1995
Human anti-streptokinase antibodies induce platelet aggregation in an Fc receptor (CD32) dependent manner
J Lebrazi, G Helft, M Abdelouahed, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
July 1, 1997
[Anti-streptokinase antibodies]
G Helft, T Lecompte, C Le Feuvre, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
September 24, 1999
Workshop I: The potential role of new therapies in deep vein thrombosis prophylaxis
A T Cohen, A S Gallus, S Haas, et al.
Journal of Clinical Pharmacology
|
July 1, 1988
The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg
A M Frydman, L Bara, Y Le Roux, et al.
Presse Medicale (Paris, France : 1983)
|
February 7, 1998
[Thrombogenicity of biomaterials in cardiovascular surgery. Methods for improving the thrombogenicity of cardiovascular prostheses]
G Babatasi, L Bara, M Massetti, et al.
Thrombosis and Haemostasis
|
May 1, 1997
Coronary stenting in a hemophilic patient
G Helft, J P Metzger, M M Samama, et al.
Seminars in Vascular Medicine
|
November 23, 2005
D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implications
M M Samama, M H Horellou, I Elalamy, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1995
Heparin- and streptokinase-dependent platelet-activating immunoglobulin G: mechanism and diagnosis
T Lecompte, N Stieltjes, L Shao-Kai, et al.
Presse Medicale (Paris, France : 1983)
|
February 7, 1998
[Thombogenicity of biomaterials in cardiovascular surgery. Thrombo-protection and different types of grafts]
G Babatasi, L Bara, M Massetti, et al.
Page
of 19